Founder & CEO at ReviveMed | AI-enabled Precision Medicine | 35 innovator under 35 | TED Speaker | MIT PhD
I'm thrilled to share that our abstract, showcasing our AI-driven metabolomics platform, has been selected for presentation at the upcoming #ASCO conference in Chicago, May 31 - June 4. Despite the transformative impact of cancer #immunotherapy, a significant number of patients do not respond to treatment. Our platform leverages #AI to analyze blood #metabolites in ccRCC—the most common form of kidney cancer—to predict which patients will benefit from immunotherapy before treatment begins. Join us at ASCO to learn how our platform is paving the way for advancing #precision medicine.
